You are on page 1of 6

PHARMACOLOGY

LAB: (MIMS)

DRUG REGULATION DD, Rx -Dangerous drugs as listed in the comprehensive Dangerous Drugs Act of 2002 supplied only on Special DOH Prescription Form (Yellow Rx) by licensed PDEA prescribing physician. EDD, Rx -Medicine containing any amount of prohibited or regulated drugs supplied on ordinary prescription forms with S-2 license number by a licensed PDEA prescribing physician. Rx -prescription medicine supplied on prescription only Non-Rx -non-prescription medicine supplied without need for prescription

MIMS CLASSIFICATION INDEX I. GASTROINTESTINAL & HEPATOBILIARY SYSTEM 1. Antacids, Antireflux Agents & Antiulcerants 2. GIT Regulators, Antiflatulents & Anti-Inflammatories 3. Antispasmodics 4. Antidiarrheals 5. Laxatives, Purgatives 6. Digestives 7. Cholagogues, Cholelitholytics and Hepatic Protectors 8. Anorectal Praparations 9. Antiemetics 10. Other Gastrointestinal Drug II. CARDIOVASCULAR & HEMATOPOIETIC SYSTEM 11. Cardiac Drugs 12. Anti-Anginal Drugs 13. ACE Inhibitors 14. Beta-Blockers 15. Calcium Antagonist 16. Angiotensin II Antagonist 17. Other Antihypertensive 18. Diuretics 19. Antidiuretics 20. Peripheral Vasodilatiors & Cerebral Activators 21. Vasoconstrictors

22. Dyslipidaemic Agents 23. Haemostatics 24. Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics 25. Phlebitis & Varicose Preparations 26. Haemorrheologicals 27. Haematopoietic Agents 28. Other Cardiovascular Drugs III. RESPIRATORY SYSTEM 1. 2. 3. 4. 5. Respiratory Stimulants Antiasthmatic & COPD Preparations Cough & Cold Preparations Nasal Decongestants & other Nasal Preparations Other Drugs Acting on the Respiratory System IV. CENTRAL NERVOUS SYSTEM 6. Anxiolytics 7. Hypnotics & Sedatives 8. Antidepressants 9. Antipsychotics 10. Anticonvulsants 11. Other CNS Drugs & Agents for ADHD 12. Neurodegenerative Disease Drugs 13. Antiparkinsonian Drugs 14. Antivertigo Drugs 15. Analgesics (Opioid) 16. Analgesics (Non-Opioid) & Antipyretics 17. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) 18. Drugs for Neuropathic Pain 19. Antimigraine Preparations 20. Nootropics & Neurotonics

V. MUSCULO-SKELETAL SYSTEM 21. Disease-Modifying Anti-Rheumatic Drugs (DMARDs) 22. Hyperuricemia & Gout Preparations 23. Muscles Relaxants 24. Anti-Inflammatory Enzymes 25. Neuromuscular Disorder Drugs 26. Other Drugs Acting on the Musculo-Skeletal System

VI. HORMONES 27. Androgens & Related Synthetic Drugs 28. Oestrogens & Progesterones & Related Synthetic Drugs 29. Combined Sex Hormones 30. Corticosteroid Hormones 31. Trophic Hormones & Related Synthetic Drugs 32. Anabolic Agents 33. Other Drugs Affecting Hormonal Regulation VII. CONTRACEPTIVE AGENTS 34. Oral Contraceptives 35. Depot Contraceptives 36. Other Contraceptives VIII. ANTI-INFECTIVES (SYSTEMATIC) 1. Aminoglycosides 2. Cephalosporins 3. Penicillins 4. Other Beta-Lactams 5. Chloramphenicols 6. Macrolides 7. Quinolones 8. Tetracyclines 9. Sulphonamides 10. Antibacterial Combinations 11. Other Antibiotics 12. Anti-TB Agents 13. Antileprotics 14. Antifungals 15. Antivirals 16. Anthelmintics 17. Antimalarials 18. Antiamoebics 19. Other Antiprotozoal Agents IX. ONCOLOGY 20. Cytotoxic Chermotherapy 21. Hormonal Chermotherapy 22. Immunological Chermotherapy 23. Targeted Cancer Therapy

24. Supportive Care Therapy X. GENITO-URINARY SYSTEM 25. Preparation for Vaginal Conditions 26. Urinary Antiseptics 27. Drugs Acting on the Uterus 28. Drugs for erectile Dysfunction 29. Drugs for Bladder & Prostate Disorders 30. Other Drugs Acting on the Genito-Urinary System XI. ENDOCRINE & METABOLIC SYSTEM 31. Insulin Preparation 32. Antidiabetic Agents 33. Thyroid Hormones 34. Antithyroid Agents 35. Anti-Obesity Agents 36. Agents Affecting Bone Metabolism 37. Other Agents Affecting Metabolism XII. VITAMINS & MINERALS 1. 2. 3. 4. 5. 6. 7. 8. Vitamins A, D, & E Vitamin B Complex with C Vitamins C Calcium / with Vitamins Vitamins &/or Minerals Vitamins & Minerals (Geriatric) Vitamins & Minerals (Paediatrics) Vitamins & Minerals (Pre- & Post Natal) / Antianemics XIII. NUTRITION 9. Infant Nutritional Products 10. Enteral/Nutritional Products 11. Parenteral Nutrional Products 12. Electrolytes 13. Appetite Enhancers 14. Supplements & Adjuvant Therapy XIV. EYE 15. Eye Anti-Infectives & Antiseptics 16. Eye Antiseptics with Corticosteroids

17. Eye Corticosteroids 18. Mydriatic Drugs 19. Miotic Drugs 20. Antiglaucoma Preparations 21. Opthalmic Decongestants, Anesthetics, Anti-Inflammatories 22. Ophthalmic Lubricants 23. Other Eye Preparations XV. EAR & MOUTH/THROAT 24. Ear Anti-Infectives & Antiseptics 25. Ear Antiseptics with Corticosteroids 26. Ear Corticosteroids 27. Other Ear Preparations 28. Mouth / Throat Preparations XVI. DERMATOLOGICALS 29. Topical Antibiotics 30. Topical Antifungals & Antiparasites 31. Topical Antivirals 32. Topical Anti-Infectives with Corticosteroids 33. Topical Corticosteroids 34. Acne Treament Preparations 35. Topical Antihistamines / Antipruritics 36. Psoriasis, Seborrhea & Ichthyosis Preparation 37. Keratolytics 38. Emollients & Skin Protectives 39. Skin Antiseptics & Disinfectants 40. Medicated Surgical Dressing 41. Other Dermatologicals XVII. ANAESTHETICS LOCAL & GENERAL XVIII. ALLERGY & IMMUNE SYSTEM 1. Antihistamines & Antiallergics 2. Vaccines, Antisera & Immunologicals 3. Immunosuppressants XIX. ANTIDOTES, DETOXIFYING AGENTS, DRUGS USED IN SUBSTANCE DEPENDENCE XX. INTRAVENOUS & OTHER STERILE SOLUTIONS

XXI. MISCELLENEOUS

PREGNANCY SAFETY INDEX CATEGORY A: Controlled studies in women fail to demonstrate a risk to the foetal in the 1st semester (and there is no evidence of a risk in later trimesters) and the possibility to foetal harm remains remote. CATEGORY B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the first trimester (and there is no evidence to a risk later trimesters). CATEGORY C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. CATEGORY D: There is a positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., If the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). CATEGORY X: Studies in animals or human beings have demonstrated foetal abnormalities or there is evidence of foetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contradicted in women who are or may become pregnant.